1-20 of 31
Marie von Lilienfeld-Toal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

Friederike Bachmann, MD, Swantje Held, Monika Engelhardt, MD, Christian Langer, MD, Denise Wolleschak, Janik Fleissner, Lars-Olof Mügge, MD, Heinz Duerk, MD PhD, Martin Schreder, MD, Kerstin Schaefer-Eckart, MD, Igor-Wolfgang Blau, MD PhD, Martin Gramatzki, MD, Peter Liebisch, MD, Albrecht Reichle, MD, Ivana Metzler, MD, Florian Bassermann, MD PhD, Bernd Metzner, MD PhD, Christoph Röllig, MD MSC, Bernd Hertenstein, Tobias Dechow, Wolfram Jung, MD, Helmut Ostermann, MD, Holger Hebart, Georg Maschmeyer, MD, Hans Jürgen Salwender, MD, Marie von Lilienfeld-Toal, MD, Kai-Uwe Eckardt, MD, Christian Straka, MD PhD, Hermann Einsele, MD, Stefan Knop
Journal: Blood
Blood (2019) 134 (Supplement_1): 1840.
https://doi.org/10.1182/blood-2019-125235
Published: 2019
Journal Articles

Full Dose or Reduced Dose Melphalan (MEL) for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): A Single Center Analysis on 187 Consecutive Patients

Annamaria Brioli, MD, vom Hofe Felix, Lars-Olof Mügge, MD, Sebastian Scholl, MD, Inken Hilgendorf, MD, Herbert G. Sayer, MD PhD, Olaposi Yomade, MD, Thomas Ernst, Andreas Hochhaus, MD, Marie von Lilienfeld-Toal, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4625.
https://doi.org/10.1182/blood-2018-99-112045
Published: 2018
Journal Articles

Induction with Bortezomib Melphalan and Prednisolon (VMP) Is Associated with Unexpectedly High Discontinuation Rate in Elderly Multiple Myeloma Patients: First Analysis of the German Maintenance (GERMAIN) Trial

Annamaria Brioli, MD, Kirsi Manz, Mathias Hänel, MD, Markus Pfirrmann, PhD, Andreas Christoph Schwarzer, MD, Marie von Lilienfeld-Toal, MD, Gabriele Prange-Krex, Christian Fabisch, PhD, Stefan Knop, Thomas Illmer, MD, Beate Krammer-Steiner, Andreas Hochhaus, MD, Lars-Olof Mügge, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2016.
https://doi.org/10.1182/blood-2018-99-115964
Published: 2018
Journal Articles

Improved Outcome with ATRA-Arsenic Trioxide Compared to ATRA-Chemotherapy in Non-High Risk Acute Promyelocytic Leukemia – Updated Results of the Italian-German APL0406 Trial on the Extended Final Series

Uwe Platzbecker, MD, Giuseppe Avvisati, MD, Gerhard Ehninger, MD, Laura Cicconi, MD, Christian Thiede, MD, Felicetto Ferrara, MD, Sonia Maria Orlando, B.Sc., Marco Vignetti, MD, Giorgina Specchia, MD, Marco Sborgia, Eros Di Bona, MD, Massimo Breccia, MD, Elisa Cerqui, MD, Konstanze Döhner, MD, Walter Fiedler, MD, Marie von Lilienfeld-Toal, MD, Bernd Hertenstein, MD, Helmut R. Salih, MD, Mohammed Wattad, MD, Michael Lübbert, Christian H. Brandts, MD, Mathias Hänel, MD, Norbert Schmitz, MD, Hartmut Link, MDPhD, Mariadomenica Divona, B.Sc., Chiara Frairia, MD, Enrico Maria Pogliani, MD, Claudio Fozza, MD, Alfonso Maria D'Arco, MD, Nicola Di Renzo, MD, Agostino Cortelezzi, MD, Francesco Fabbiano, MD, Paola Fazi, MD, Johannes Kullmer, MD, Walter E. Aulitzky, MD, Stefan W. Krause, MD, Hans Salwender, MD, Kerstin Schäfer-Eckart, MD, Markus P. Radsak, MD, Arnold Ganser, Hartmut Döhner, MD, Sergio Amadori, MD, Franco Mandelli, MD, Richard F. Schlenk, MD, Francesco Lo-Coco, MD
Journal: Blood
Blood (2014) 124 (21): 12.
https://doi.org/10.1182/blood.V124.21.12.12
Published: 2014
Journal Articles

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)

Verena I. Gaidzik, Richard F. Schlenk, Peter Paschka, Anja Stölzle, Daniela Späth, Andrea Kuendgen, Marie von Lilienfeld-Toal, Wolfram Brugger, Hans Günter Derigs, Stephan Kremers, Richard Greil, Aruna Raghavachar, Mark Ringhoffer, Helmut R. Salih, Mohammed Wattad, Heinz G. Kirchen, Volker Runde, Gerhard Heil, Andreas L. Petzer, Michael Girschikofsky, Michael Heuser, Sabine Kayser, Gudrun Goehring, Maria-Veronica Teleanu, Brigitte Schlegelberger, Arnold Ganser, Jürgen Krauter, Lars Bullinger, Hartmut Döhner, Konstanze Döhner
Journal: Blood
Blood (2013) 121 (23): 4769–4777.
https://doi.org/10.1182/blood-2012-10-461624
Published: 2013
Includes: Supplemental data
Journal Articles

Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG)

Peter Paschka, Juan Du, Richard F. Schlenk, Verena I. Gaidzik, Lars Bullinger, Andrea Corbacioglu, Daniela Späth, Sabine Kayser, Brigitte Schlegelberger, Jürgen Krauter, Arnold Ganser, Claus-Henning Köhne, Gerhard Held, Marie von Lilienfeld-Toal, Heinz Kirchen, Mathias Rummel, Katharina Götze, Heinz-August Horst, Mark Ringhoffer, Michael Lübbert, Mohammed Wattad, Helmut R. Salih, Andrea Kündgen, Hartmut Döhner, Konstanze Döhner
Journal: Blood
Blood (2013) 121 (1): 170–177.
https://doi.org/10.1182/blood-2012-05-431486
Published: 2013
Includes: Supplemental data
Journal Articles

Prognostic Impact of Mutant to Wild-Type Ratio and Insertion Site in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication

Sabine Kayser, Richard F Schlenk, MD, Jürgen Krauter, Claus-Henning Köhne, Ulrich Germing, Gerhard Held, Heinz A. Horst, Mark Ringhoffer, MD, Marie von Lilienfeld-Toal, Mathias J. Rummel, MD, Katharina Götze, MD, David Nachbaur, Brigitte Schlegelberger, Gudrun Göhring, MD, Helmut R Salih, MD, Hans Martin, Wolfgang Herr, Michael Lübbert, MD, Hans-Jürgen Salwender, Patricia Erdmann, Peter Paschka, Verena I. Gaidzik, MD, Ph.D, Veronica Teleanu, MD, Daniela Späth, Arnold Ganser, Thomas Fischer, MD, Hartmut Döhner, MD, Konstanze Döhner, MD, Ph.D
Journal: Blood
Blood (2012) 120 (21): 785.
https://doi.org/10.1182/blood.V120.21.785.785
Published: 2012
Journal Articles

ATRA and Arsenic Trioxide (ATO) Versus ATRA and Idarubicin (AIDA) for Newly Diagnosed, Non High-Risk Acute Promyelocytic Leukemia (APL): Results of the Phase III, Prospective, Randomized, Intergroup APL0406 Study by the Italian-German Cooperative Groups Gimema-SAL-AMLSG

Francesco Lo-Coco, MD, Giuseppe Avvisati, MD, PhD, Sonia Maria Orlando, Felicetto Ferrara, MD, Marco Vignetti, MD, Paola Fazi, MD, Eros Di Bona, MD, Giorgina Specchia, MD, Simona Sica, MD, Mariadomenica Divona, Alessandro Levis, MD, Walter Fiedler, MD, Elisa Cerqui, MD, Massimo Breccia, Giuseppe Fioritoni, MD, Helmut R Salih, MD, Christian H. Brandts, Enrica Morra, MD, Marie von Lilienfeld-Toal, MD, Bernd Hertenstein, Mohammed Wattad, MD, Michael Lubbert, MD, Matthias Hänel, MD, Norbert Schmitz, MD, Hartmut Link, MD, Maria Grazia Kropp, MD, Alessandro Rambaldi, MD, Giorgio La Nasa, MD, Mario Luppi, Fabio Ciceri, MD, Michaela Sauer, Hartmut Dohner, MD, Arnold Ganser, Franco Mandelli, MD, Gerhard Ehninger, Sergio Amadori, MD, Christian Thiede, Richard F Schlenk, MD, Uwe Platzbecker, MD
Journal: Blood
Blood (2012) 120 (21): 6.
https://doi.org/10.1182/blood.V120.21.6.6
Published: 2012
Journal Articles

TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome

Frank G. Rücker, Richard F. Schlenk, Lars Bullinger, Sabine Kayser, Veronica Teleanu, Helena Kett, Marianne Habdank, Carla-Maria Kugler, Karlheinz Holzmann, Verena I. Gaidzik, Peter Paschka, Gerhard Held, Marie von Lilienfeld-Toal, Michael Lübbert, Stefan Fröhling, Thorsten Zenz, Jürgen Krauter, Brigitte Schlegelberger, Arnold Ganser, Peter Lichter, Konstanze Döhner, Hartmut Döhner
Journal: Blood
Blood (2012) 119 (9): 2114–2121.
https://doi.org/10.1182/blood-2011-08-375758
Published: 2012
Includes: Supplemental data
Journal Articles

Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies

Clinical Trials & Observations
Sabine Kayser, Manuela Zucknick, Konstanze Döhner, Jürgen Krauter, Claus-Henning Köhne, Heinz A. Horst, Gerhard Held, Marie von Lilienfeld-Toal, Sibylla Wilhelm, Mathias Rummel, Ulrich Germing, Katharina Götze, David Nachbaur, Brigitte Schlegelberger, Gudrun Göhring, Daniela Späth, Carina Morlok, Veronica Teleanu, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk, for the German-Austrian AML Study Group
Journal: Blood
Blood (2012) 119 (2): 551–558.
https://doi.org/10.1182/blood-2011-07-367508
Published: 2012
Includes: Supplemental data
Journal Articles

Novel treatment concepts for graft-versus-host disease

Dominik Wolf, Marie von Lilienfeld-Toal, Anna Maria Wolf, Michael Schleuning, Michael von Bergwelt-Baildon, Stefanie A. E. Held, Peter Brossart
Journal: Blood
Blood (2012) 119 (1): 16–25.
https://doi.org/10.1182/blood-2011-08-339465
Published: 2012
Journal Articles

TP53 Alterations in Acute Myeloid Leukemia with Complex Karyotype Correlate with Specific Copy Number Alterations, Monosomal Karyotype, and Dismal Outcome,

Frank G. Rücker, Richard F. Schlenk, MD, Lars Bullinger, Sabine Kayser, Veronica Teleanu, Helena Kett, Marianne Habdank, Carla-Maria Kugler, Karlheinz Holzmann, Verena I. Gaidzik, MD, Peter Paschka, MD, Gerhard Held, Marie von Lilienfeld-Toal, Michael Lübbert, Stefan Fröhling, Thorsten Zenz, Jürgen Krauter, Brigitte Schlegelberger, M.D., Arnold Ganser, MD, Peter Lichter, Konstanze Döhner, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2011) 118 (21): 3558.
https://doi.org/10.1182/blood.V118.21.3558.3558
Published: 2011
Journal Articles

All- Trans Retinoic Acid Improves Outcome in Younger Adult Patients with Nucleophosmin-1 Mutated Acute Myeloid Leukemia – Results of the AMLSG 07-04 Randomized Treatment Trial

Richard F. Schlenk, MD, Konstanze Döhner, MD, Jürgen Krauter, MD, Verena I. Gaidzik, MD, Peter Paschka, MD, Michael Heuser, MD, Thomas Kindler, MD, Michael Lübbert, MD, PhD, Hans Martin, MD, Helmut R. Salih, MD, Andrea Kuendgen, MD, Heinz A. Horst, MD, Marie von Lilienfeld-Toal, MD, Katharina Götze, David Nachbaur, MD, Mohammed Wattad, MD, Claus-Henning Köhne, MD, Walter Fiedler, MD, Martin Bentz, MD, Gerald Wulf, Gerhard Held, Bernd Hertenstein, MD, Hans-Günther Mergenthaler, MD, Hans Salwender, MD, Mathias J. Rummel, MD, PhD, Aruna Raghavachar, MD, Axel Benner, Dipl.Stat, Brigitte Schlegelberger, MD, Arnold Ganser, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2011) 118 (21): 80.
https://doi.org/10.1182/blood.V118.21.80.80
Published: 2011
Journal Articles

ASXL1 Mutations Predict for Resistance to Chemotherapy and Inferior Outcome in Younger Adult Patients with Acute Myeloid Leukemia (AML): A Study of the German-Austrian AMLSG

Peter Paschka, MD, Richard F. Schlenk, MD, Julia Herzig, Teresa Aulitzky, Verena I. Gaidzik, MD, Lars Bullinger, Marianne Habdank, Andrea Corbacioglu, PhD, Daniela Späth, Claus-Henning Köhne, MD, Andrea Kündgen, MD, Marie von Lilienfeld-Toal, Gerhard Held, Heinz A. Horst, MD, Katharina Götze, Martin Bentz, MD, Jürgen Krauter, MD, Arnold Ganser, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2011) 118 (21): 412.
https://doi.org/10.1182/blood.V118.21.412.412
Published: 2011
Journal Articles

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

Clinical Trials & Observations
Sabine Kayser, Konstanze Döhner, Jürgen Krauter, Claus-Henning Köhne, Heinz A. Horst, Gerhard Held, Marie von Lilienfeld-Toal, Sibylla Wilhelm, Andrea Kündgen, Katharina Götze, Mathias Rummel, David Nachbaur, Brigitte Schlegelberger, Gudrun Göhring, Daniela Späth, Carina Morlok, Manuela Zucknick, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk, for the German-Austrian AMLSG
Journal: Blood
Blood (2011) 117 (7): 2137–2145.
https://doi.org/10.1182/blood-2010-08-301713
Published: 2011
Includes: Supplemental data
Journal Articles

Impact of Allogeneic Transplantation From Matched Related and Unrelated Donors on Clinical Outcome In Younger Adult AML Patients with FLT3 Internal Tandem Duplications

Sabine Kayser, MD, Konstanze Döhner, MD, Jürgen Krauter, MD, Jochen Casper, MD, Heinz A. Horst, MD, PhD, Gerhard Held, MD, Sibylla Wilhelm, MD, Guido Kobbe, MD, Michael Lübbert, MD, Helmut R. Salih, MD, Katharina Götze, MD, Mathias J. Rummel, MD, PhD, Walter Fiedler, MD, Marie von Lilienfeld-Toal, MD, David Nachbaur, MD, Mohammed Wattad, MD, Daniela Späth, Patricia Erdmann, Arnold Ganser, MD, Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2010) 116 (21): 909.
https://doi.org/10.1182/blood.V116.21.909.909
Published: 2010
Journal Articles

Targeting Syk (spleen tyrosine kinase) Inhibits the Proliferation, Migration and Viability of Multiple Myeloma Cells

Ruth-Miriam Körber, Stefanie AE Held, Solveig Daecke, Marie von Lilienfeld-Toal, MD, Anita Bringmann, Peter Brossart, MD
Journal: Blood
Blood (2010) 116 (21): 4071.
https://doi.org/10.1182/blood.V116.21.4071.4071
Published: 2010
Journal Articles

Open-Label, Multi-Center Phase I Dose Escalation Study with Lenalidomide In Patients with Acute Myeloid Leukemia

Marie-Luise Huetter, MD, Walter Fiedler, MD, Andrea Kuendgen, MD, Juergen Krauter, MD, Marie von Lilienfeld-Toal, MD, Sabine Kayser, MD, Heidi Rafler, Hartmut Doehner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2010) 116 (21): 3297.
https://doi.org/10.1182/blood.V116.21.3297.3297
Published: 2010
Journal Articles

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study

Clinical Trials & Observations
Bob Löwenberg, Joachim Beck, Carlos Graux, Wim van Putten, Harry C. Schouten, Leo F. Verdonck, Augustin Ferrant, Pieter Sonneveld, Mojca Jongen-Lavrencic, Marie von Lilienfeld-Toal, Bart J. Biemond, Edo Vellenga, Dimitri Breems, Hilde de Muijnck, Ron Schaafsma, Gregor Verhoef, Hartmut Döhner, Alois Gratwohl, Thomas Pabst, Gert J. Ossenkoppele, Johan Maertens, for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), German Austrian AML Study Group (AMLSG), Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)
Journal: Blood
Blood (2010) 115 (13): 2586–2591.
https://doi.org/10.1182/blood-2009-10-246470
Published: 2010
Journal Articles

Outcome of Fungal Infection in Patients Undergoing Myelosuppressive Chemotherapy in a Tertiary Care Centre During 12 Years (1995-2006).

Marie von Lilienfeld-Toal, MD, Axel Glasmacher, MD, Günter Marklein, MD, Peter Brossart, MD, Corinna Hahn-Ast, PhD
Journal: Blood
Blood (2009) 114 (22): 1384.
https://doi.org/10.1182/blood.V114.22.1384.1384
Published: 2009